Anbio Biotechnology (NASDAQ:NNNN) Stock Falls 4.8% – Here’s What Happened

Anbio Biotechnology (NASDAQ:NNNN)’s share price fell 4.8% during mid-day trading on Friday. The stock traded as low as $6.12 and last traded at $5.99. 3,216 shares changed hands during trading, a decline of 96% from the average session volume of 79,229 shares. The stock had previously closed at $6.29.

Wall Street Analyst Weigh In

Separately, Weiss Ratings lowered shares of Anbio Biotechnology from a “hold (c-)” rating to a “sell (d+)” rating in a report on Wednesday, July 29th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company presently has an average rating of “Sell”.

Anbio Biotechnology Stock Down 4.8%

The stock has a 50-day simple moving average of $7.81 and a 200 day simple moving average of $17.01.

About Anbio Biotechnology

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.